38
Participants
Start Date
February 28, 2014
Primary Completion Date
January 14, 2016
Study Completion Date
October 2, 2017
Brentuximab Vedotin
Monoclonal antibody drug conjugate
Queen Elizabeth Hospital, Birmingham
University Hospital of Wales, Cardiff
Beatson West of Scotland Cancer Center, Glasgow
St James University Hospital, Leeds
University Hospital, Leicester
Royal Liverpool Hospital, Liverpool
Guys Hospital, London
The Freeman Hospital, Newcastle
Norfolk and Norwich Hospital, Norwich
The Churchill Hospital, Oxford
Southampton General Hospital, Southampton
The Christie Hospital, Manchester
Collaborators (1)
Leukaemia Lymphoma Research
OTHER
Millennium Pharmaceuticals, Inc.
INDUSTRY
University of Birmingham
OTHER